Bridger Management LLC Purchases New Holdings in UnitedHealth Group Incorporated $UNH

Bridger Management LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 23,699 shares of the healthcare conglomerate’s stock, valued at approximately $9,850,000. UnitedHealth Group makes up approximately 6.6% of Bridger Management LLC’s investment portfolio, making the stock its 4th largest holding.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Glenview Trust Co acquired a new position in UnitedHealth Group during the second quarter valued at $2,319,000. Maxele Advisors LLC purchased a new position in UnitedHealth Group during the 2nd quarter valued at about $466,000. Empowered Funds LLC increased its holdings in shares of UnitedHealth Group by 21.1% in the 2nd quarter. Empowered Funds LLC now owns 139,558 shares of the healthcare conglomerate’s stock valued at $58,004,000 after purchasing an additional 24,274 shares during the period. United Capital Financial Advisors LLC boosted its holdings in shares of UnitedHealth Group by 6.0% during the second quarter. United Capital Financial Advisors LLC now owns 36,707 shares of the healthcare conglomerate’s stock worth $15,256,000 after purchasing an additional 2,087 shares during the period. Finally, E Wealth Partners LLC increased its stake in UnitedHealth Group by 4.8% in the 2nd quarter. E Wealth Partners LLC now owns 1,297 shares of the healthcare conglomerate’s stock valued at $539,000 after buying an additional 59 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.19% of the company’s stock.

UnitedHealth Group Trading Down 0.3%

NYSE:UNH opened at $393.99 on Friday. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The company’s 50 day moving average is $413.28 and its 200-day moving average is $360.11. The firm has a market cap of $353.64 billion, a price-to-earnings ratio of 25.35, a P/E/G ratio of 1.36 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter last year, the firm posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 19.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is 59.72%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on UNH shares. JPMorgan Chase & Co. boosted their price target on shares of UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. Bank of America restated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 20th. HSBC raised their price target on UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a research note on Monday, July 6th. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research report on Friday, July 17th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, June 11th. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $456.56.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.